NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

Clinical trial NCT04623944 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04623944
Sponsor: Nkarta, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory AML AML, Adult MDS Refractory Myelodysplastic Syndromes

Start date: 2020-09-21
Primary completion: 2024-10-02
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.